Aktieselskabet Schouw & Co.
Schouw & Co. share buy-back programme, week 49 2024
Schouw & Co. share buy-back programme, week 49 2024
On 4 March 2024, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 13 of 1 March 2024. Under the programme, Schouw & Co. will acquire shares for up to DKK 200 million during the period 4 March 2024 to 31 December 2024.
The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).
| Trading day | No. of shares | Average price | Amount | ||
| Accumulated until 29/11/2024 | 324,887 | 558.67 | 181,504,498 | ||
| Monday, 2 December 2024 | 2,000 | 558.64 | 1,117,280 | ||
| Tuesday, 3 December 2024 | 2,000 | 553.11 | 1,106,220 | ||
| Wednesday, 4 December 2024 | 2,000 | 551.69 | 1,103,380 | ||
| Thursday, 5 December 2024 | 2,000 | 550.12 | 1,100,240 | ||
| Friday, 6 December 2024 | 2,000 | 551.42 | 1,102,840 | ||
| In the period 2/12/2024 - 6/12/2024 | 10,000 | 553.00 | 5,529,960 | ||
| Accumulated 4/3/2024 - 6/12/2024 | 334,887 | 558.50 | 187,034,458 | ||
| Following the above transactions Schouw & Co. holds a total of 1,945,813 treasury shares corresponding to 7.78% of the total share capital of 25,000,000 shares. | |||||
Aktieselskabet Schouw & Co.
Jørgen Dencker Wisborg, Chairman
Jens Bjerg Sørensen, President, telephone number +45 86 11 22 22
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S17.9.2025 23:05:02 CEST | Press release
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study
Biogen Inc.17.9.2025 22:30:05 CEST | Press release
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
Atico Mining Corporation17.9.2025 22:30:00 CEST | Press release
Atico Signs the Investment Protection Agreement with Government of Ecuador for its La Plata Project
Frontline plc.17.9.2025 22:06:51 CEST | Press release
FRO – Filing of Half Yearly Report
VCI Global Limited17.9.2025 21:00:00 CEST | Press release
VCI Global Initiates Rescission and Cancellation of Shares from QuantGold Transaction, Tightening Capital Structure Following Reverse Split
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom